KU Chow, WD Sommerlad, S Boehrer, B Schneider, G Seipelt, MJ Rummel, D Hoelzer, PS Mitrou, E Weidmann. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. haematol [Internet]. 2002Jan.1 [cited 2024Nov.23];87(1):33-. Available from: https://haematologica.org/article/view/2234